Cogent Biosciences, Inc.

NASDAQ:COGT

8.12 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q32015 Q3
Revenue 0005.5880000000000000.3120.5287.03115.2881.023.1383.0533.8052.0431.6662.222.1232.3312.0791.82752.1761.002
Cost of Revenue 01.081.0660.7940.8551.2160.7230.9373.7110.0970.0690.0680.0480.0140.0176.1085.0035.1299.49810.35410.33510.61711.510000000039.6580.766
Gross Profit 0-1.08-1.0664.794-0.855-1.216-0.723-0.937-3.711-0.097-0.069-0.068-0.048-0.014-0.017-6.108-4.691-4.601-2.4674.934-9.315-7.479-8.4573.8052.0431.6662.222.1232.3312.0791.82712.5180.236
Gross Profit Ratio 0000.85800000000000-776,013,213,059.602-15.035-8.714-0.3510.323-9.132-2.383-2.77111111110.240.236
Reseach & Development Expenses 63.61454.29452.70548.71950.12738.87136.03836.74229.93629.47925.4720.51414.79812.3888.2136.10751.9135.1299.49810.35410.33510.61712.40310.76510.2529.1268.1427.5628.1777.1416.95200
General & Administrative Expenses 11.810.0939.6999.5099.4538.2147.1997.0036.8856.3765.9485.1265.0214.9044.5875.3485.5982.8023.6742.6942.7213.0622.4912.0442.3671.9791.0641.4411.3240.9710.94417.6694.178
Selling & Marketing Expenses 00000000000000000000000000000003.6990.524
SG&A 11.810.0939.6999.5099.4538.2147.1997.0036.8856.3765.9485.1265.0214.9044.5875.3485.5982.8023.6742.6942.7213.0622.4912.0442.3671.9791.0641.4411.3240.9710.94421.3684.702
Other Expenses 00-0.001-0.00700.2682.3822.0170.2590.6560.6770.6210.620.6230.9470.015-0.270.0070-0.0040.08200-0.010.0030.1570.170.0910.070.0730.0400
Operating Expenses 75.41464.38762.40458.22859.5847.08543.23743.74536.82135.85531.41825.6419.81917.29212.811.45557.5117.93113.17213.04813.05613.67914.89412.80912.61911.1059.2069.0039.5018.1127.89624.8754.759
Operating Income -75.414-64.387-62.404-58.228-59.58-47.085-43.237-43.745-36.821-35.855-31.418-25.64-19.819-17.292-12.8-11.455-57.199-7.403-6.1412.24-12.036-10.541-11.841-9.004-10.576-9.439-6.986-6.88-7.17-6.033-6.069-12.357-4.523
Operating Income Ratio 000-10.4200000000000-1,455,342,396,137.721-183.33-14.021-0.8730.147-11.8-3.359-3.878-2.366-5.177-5.666-3.147-3.241-3.076-2.902-3.322-0.237-4.514
Total Other Income Expenses Net 4.785.4374.0563.8634.1983.0094.654.1271.7590.9280.7840.7280.7350.7431.0720.1187.2160.010.0470.0570.1130.0250.150.3980.4080.4160.2510.190.170.170.13-1.88-0.003
Income Before Tax -70.634-58.95-58.348-54.365-55.382-44.076-38.587-39.618-35.062-34.927-30.634-24.912-19.084-16.549-11.728-11.339-49.983-7.393-6.0942.297-11.923-10.516-11.691-8.606-10.168-9.023-6.735-6.69-7-5.863-5.939-14.237-4.526
Income Before Tax Ratio 000-9.72900000000000-1,440,604,751,619.87-160.202-14.002-0.8670.15-11.689-3.351-3.829-2.262-4.977-5.416-3.034-3.151-3.003-2.82-3.251-0.273-4.517
Income Tax Expense 00-4.057-3.87-0.855-3.957-4.65-4.127-1.759-1.433-0.784-0.728-0.115-0.12-0.125-0.118-7.608-0.0030-0.375-0.34900-0.408-0.405-0.259-0.081-0.099-0.1-0.097-0.094.4930.124
Net Income -70.634-58.95-58.348-54.365-55.382-44.076-33.937-35.491-33.303-34.927-29.85-24.912-19.084-16.549-11.728-11.339-49.983-7.393-6.0942.297-11.923-10.516-11.691-8.606-10.168-9.023-6.735-6.69-7-5.863-5.939-9.744-4.402
Net Income Ratio 000-9.72900000000000-1,440,604,751,619.87-160.202-14.002-0.8670.15-11.689-3.351-3.829-2.262-4.977-5.416-3.034-3.151-3.003-2.82-3.251-0.187-4.393
EPS -0.64-0.59-0.62-0.63-0.64-0.59-0.48-0.5-0.48-0.71-0.66-0.57-0.48-0.43-0.34-0.59-5.07-0.95-0.810.28-1.56-1.38-1.55-1.15-1.36-1.24-2.64-1.14-1.2-1-1.01-0.77-1.17
EPS Diluted -0.64-0.59-0.62-0.63-0.64-0.59-0.48-0.5-0.48-0.71-0.66-0.57-0.48-0.43-0.34-0.59-5.07-0.95-0.810.28-1.56-1.38-1.55-1.15-1.36-1.24-2.64-1.14-0.95-0.79-0.8-0.77-1.17
EBITDA -74.317-63.307-61.805-57.63-58.999-46.523-42.708-43.325-31.351-35.758-31.349-25.572-19.771-17.278-12.783-11.439-10.167-7.117-5.8462.554-11.71-10.541-11.361-8.254-10.246-9.114-6.672-6.573-6.87-5.747-5.791-9.32-4.466
EBITDA Ratio 000-10.27800000000000-1,459,280,904,586.456-207.25-13.479-0.8310.147-11.8-3.254-3.77-2.274-5.015-5.471-3.005-3.096-2.947-2.764-3.17-0.179-4.457